comparemela.com

Page 3 - Aprilw Armstrong News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AD, JAK Inhibitors, Psoriasis Among Topics Highlighted at 2023 Fall Clinical Dermatology Conference

The 2023 Fall Clinical Dermatology conference will take place in Las Vegas and be livestreamed from October 19 to 22; topics of interest to be covered include atopic dermatitis (AD), Janus kinase (JAK) inhibitors, and psoriasis.

South australiaUnited statesLas vegasSeemalr desaiAprilw armstrongDarrels rigelElizabeth swansonJohn ym kooMona shahriariLaurak ferrisClinical dermatology conferenceAmerican journalAtopic dermatologySkin of color

New 3-Year Extension Study Results Observed for Deucravacitinib Treatment of Plaque Psoriasis

The new data on this drug’s effects on maintenance of clinical response indicates the strength of the treatment for individuals with the immune-mediated skin disease.

April armstrongAprilw armstrongKunzmannk lauren millerEuropean academy of dermatologyBristol myers squibbDrug administrationEuropean academyPsoriasis areaSeverity indexGlobal assessmentLong term data demonstrate durable efficacyConsistent safetyThree yearsModerate to severe plaqueBristol myersMerging care

UCB Anticipates Delay to FDA Bimekizumab Decision

The company shared anticipation that their BLA decision for bimekizumab to treat adults with plaque psoriasis will not come before the end of this month.

United statesButeraa bimekizumabAprilw armstrongAmerican academy of dermatologyKeck school of medicineBiologics license applicationEstablishment inspection reportAmerican academyPublished january

Physicians create guidelines for utilizing topical medications in psoriasis treatment

Physicians create guidelines for utilizing topical medications in psoriasis treatment
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Aprilw armstrongPsoriasis expert groupKeck schoolSouthern california

April W Armstrong, MD, MPH: Trial Data on Oral TYK2 Inhibitor Treatment for Psoriasis

New data discussed by Armstrong in this interview shows promising results for the once-per-day TYK2 inhibitor treatment known as TAK-279 for plaque psoriasis.

United statesAprilw armstrongKeck school of medicineAmerican academy of dermatologyAmerican academy

vimarsana © 2020. All Rights Reserved.